Works matching IS 15228517 AND DT 2020 AND VI 22 AND IP 10

Results: 21

Highlights from the Literature.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1419, doi. 10.1093/neuonc/noaa205

By:

Wright, Karen;
Abounader, Roger;
Khasraw, Mustafa;
Huse, Jason;
Gerstner, Elizabeth

Publication type:

Article

Forthcoming Meetings.

Published in:: Neuro-Oncology, 2020, v. 22, n. 10, p. 1549, doi. 10.1093/neuonc/noaa204
Publication type:: Article

Opportunities for the treatment of NF1-associated low-grade gliomas: how to decide on the best treatment options for patients?

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1415, doi. 10.1093/neuonc/noaa201

By:

Stücklin, Ana S Guerreiro;
Mueller, Sabine

Publication type:

Article

Mesenchymal stemlike cells in glioblastoma.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1409, doi. 10.1093/neuonc/noaa197

By:

Tran, Anh Nhat;
Horbinski, Craig

Publication type:

Article

Integrated analysis of pediatric low-grade glioma: clinical implications and the path forward.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1413, doi. 10.1093/neuonc/noaa187

By:

Packer, Roger J;
MacDonald, Tobey J

Publication type:

Article

Marauding monocytes, macrophages, and microglia in gliomas.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1411, doi. 10.1093/neuonc/noaa185

By:

Fults, Daniel W

Publication type:

Article

Leptomeningeal metastases: how best to assess response.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1417, doi. 10.1093/neuonc/noaa184

By:

Chamberlain, Marc C

Publication type:

Article

Utility of claims data for delineation of intracranial treatment among patients with brain metastases.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1547, doi. 10.1093/neuonc/noaa175

By:

Lamba, Nayan;
Catalano, Paul J;
Haas-Kogan, Daphne A;
Wen, Patrick Y;
Aizer, Ayal A

Publication type:

Article

iGLASS: imaging integration into the Glioma Longitudinal Analysis Consortium.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1545, doi. 10.1093/neuonc/noaa160

By:

Bakas, Spyridon;
Ormond, David Ryan;
Alfaro-Munoz, Kristin D;
Smits, Marion;
Cooper, Lee Alex Donald;
Verhaak, Roel;
Poisson, Laila M

Publication type:

Article

Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1425, doi. 10.1093/neuonc/noaa154

By:

Dunn, Gavin P;
Cloughesy, Timothy F;
Maus, Marcela V;
Prins, Robert M;
Reardon, David A;
Sonabend, Adam M

Publication type:

Article

Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1422, doi. 10.1093/neuonc/noaa142

By:

Grossman, Stuart A;
Romo, Carlos G;
Rudek, Michelle A;
Supko, Jeffrey;
Fisher, Joy;
Nabors, L Burt;
Wen, Patrick Y;
Peereboom, David M;
Ellingson, Benjamin M;
Elmquist, William;
Barker, Fred G;
Kamson, David;
Sarkaria, Jann N;
Timmer, William;
Bindra, Ranjit S;
Ye, Xiaobu

Publication type:

Article

Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1439, doi. 10.1093/neuonc/noaa103

By:

Yang, Wen-Bin;
Hsu, Che-Chia;
Hsu, Tsung-I;
Liou, Jing-Ping;
Chang, Kwang-Yu;
Chen, Pin-Yuan;
Liu, Jr-Jiun;
Yang, Shung-Tai;
Wang, Jia-Yi;
Yeh, Shiu-Hwa;
Chen, Ruei-Ming;
Chang, Wen-Chang;
Chuang, Jian-Ying

Publication type:

Article

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1505, doi. 10.1093/neuonc/noaa062

By:

Puduvalli, Vinay K;
Wu, Jing;
Yuan, Ying;
Armstrong, Terri S;
Vera, Elizabeth;
Wu, Jimin;
Xu, Jihong;
Giglio, Pierre;
Colman, Howard;
Walbert, Tobias;
Raizer, Jeffrey;
Groves, Morris D;
Tran, David;
Iwamoto, Fabio;
Avgeropoulos, Nicholas;
Paleologos, Nina;
Fink, Karen;
Peereboom, David;
Chamberlain, Marc;
Merrell, Ryan

Publication type:

Article

A combined approach of convection-enhanced delivery of peptide nanofiber reservoir to prolong local DM1 retention for diffuse intrinsic pontine glioma treatment.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1495, doi. 10.1093/neuonc/noaa101

By:

Bellat, Vanessa;
Alcaina, Yago;
Tung, Ching-Hsuan;
Ting, Richard;
Michel, Adam O;
Souweidane, Mark;
Law, Benedict

Publication type:

Article

1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine treatment after brain irradiation preserves cognitive function in mice.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1484, doi. 10.1093/neuonc/noaa095

By:

Bhat, Kruttika;
Medina, Paul;
He, Ling;
Zhang, Le;
Saki, Mohammad;
Ioannidis, Angeliki;
Nguyen, Nhan T;
Sodhi, Sirajbir S;
Sung, David;
Magyar, Clara E;
Liau, Linda M;
Kornblum, Harley I;
Pajonk, Frank

Publication type:

Article

Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1516, doi. 10.1093/neuonc/noaa094

By:

Cluceru, Julia;
Nelson, Sarah J;
Wen, Qiuting;
Phillips, Joanna J;
Shai, Anny;
Molinaro, Annette M;
Alcaide-Leon, Paula;
Olson, Marram P;
Nair, Devika;
LaFontaine, Marisa;
Chunduru, Pranathi;
Villanueva-Meyer, Javier E;
Cha, Soonmee;
Chang, Susan M;
Berger, Mitchel S;
Lupo, Janine M

Publication type:

Article

Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1474, doi. 10.1093/neuonc/noaa077

By:

Fukuoka, Kohei;
Mamatjan, Yasin;
Tatevossian, Ruth;
Zapotocky, Michal;
Ryall, Scott;
Stucklin, Ana Guerreiro;
Bennett, Julie;
Nobre, Liana Figueiredo;
Arnoldo, Anthony;
Luu, Betty;
Wen, Ji;
Zhu, Kaicen;
Leon, Alberto;
Torti, Dax;
Pugh, Trevor J;
Hazrati, Lili-Naz;
Laperriere, Normand;
Drake, James;
Rutka, James T;
Dirks, Peter

Publication type:

Article

Role of CX3CR1 signaling in malignant transformation of gliomas.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1463, doi. 10.1093/neuonc/noaa075

By:

Lee, Sungho;
Latha, Khatri;
Manyam, Ganiraju;
Yang, Yuhui;
Rao, Arvind;
Rao, Ganesh

Publication type:

Article

Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1536, doi. 10.1093/neuonc/noaa072

By:

Peng, Jian;
Zhou, Hao;
Tang, Oliver;
Chang, Ken;
Wang, Panpan;
Zeng, Xiaowei;
Shen, Qin;
Wu, Jing;
Xiao, Yanhe;
Patel, Sohil H;
Hu, Chongyu;
Jin, Ke;
Xiao, Bo;
Boxerman, Jerrold;
Gao, Xiaoping;
Wen, Patrick Y;
Bai, Harrison X;
Huang, Raymond Y;
Yang, Li

Publication type:

Article

A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1527, doi. 10.1093/neuonc/noaa071

By:

Ullrich, Nicole J;
Prabhu, Sanjay P;
Reddy, Alyssa T;
Fisher, Michael J;
Packer, Roger;
Goldman, Stewart;
Robison, Nathan J;
Gutmann, David H;
Viskochil, David H;
Allen, Jeffrey C;
Korf, Bruce;
Cantor, Alan;
Cutter, Gary;
Thomas, Coretta;
Perentesis, John P;
Mizuno, Tomoyuki;
Vinks, Alexander A;
Manley, Peter E;
Chi, Susan N;
Kieran, Mark W

Publication type:

Article

Crosstalk between GBM cells and mesenchymal stemlike cells promotes the invasiveness of GBM through the C5a/p38/ZEB1 axis.

Published in:

Neuro-Oncology, 2020, v. 22, n. 10, p. 1452, doi. 10.1093/neuonc/noaa064

By:

Lim, Eun-Jung;
Kim, Seungmo;
Oh, Yoonjee;
Suh, Yongjoon;
Kaushik, Neha;
Lee, Ji-Hyun;
Lee, Hae-June;
Kim, Min-Jung;
Park, Myung-Jin;
Kim, Rae-Kwon;
Cha, Junghwa;
Kim, Se Hoon;
Shim, Jin-Kyoung;
Choi, Junjeong;
Chang, Jong Hee;
Hong, Yong Kil;
Huh, Yong Min;
Kim, Pilnam;
Kang, Seok-Gu;
Lee, Su-Jae

Publication type:

Article